Insider Transactions in Q4 2021 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2021
|
Ian Clements Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
750
+3.88%
|
$9,750
$13.9 P/Share
|
|
Nov 24
2021
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
7,000
+19.98%
|
$98,000
$14.4 P/Share
|
|
Nov 24
2021
|
Ian Clements Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+3.78%
|
$9,800
$14.4 P/Share
|
|
Nov 10
2021
|
Ian Clements Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
458
+2.61%
|
$5,954
$13.52 P/Share
|
|
Nov 10
2021
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
753
+0.88%
|
$9,789
$13.52 P/Share
|
|
Nov 10
2021
|
Peter Radovich PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
958
+7.26%
|
$12,454
$13.52 P/Share
|
|
Nov 10
2021
|
Edwin Jonathan Tucker Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.15%
|
$910
$13.52 P/Share
|
|
Nov 10
2021
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
768
+6.86%
|
$9,984
$13.52 P/Share
|
|
Oct 01
2021
|
Edwin Jonathan Tucker Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,364
-2.89%
|
$25,916
$19.26 P/Share
|
|
Oct 01
2021
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,364
-10.79%
|
$25,916
$19.26 P/Share
|
|
Oct 01
2021
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
961
-1.13%
|
$18,259
$19.26 P/Share
|
|
Oct 01
2021
|
Ian Clements Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,574
-8.64%
|
$29,906
$19.26 P/Share
|
|
Oct 01
2021
|
Pamela Vig CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,364
-12.37%
|
$25,916
$19.26 P/Share
|
|
Oct 01
2021
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,672
-14.87%
|
$69,768
$19.26 P/Share
|